SK pharmteco

?? Announcing: The new SK pharmteco website! www.skpharmteco.com We are live! Designed with you in mind, our new site reflects our commitment to innovation, transparency, and providing best-in-class CDMO and Contract Analytical Testing solutions for our partners. Explore our new website to learn more about: ???????? ???? ???????? ???????? ?????? ????????????????: See how simplicity and transparency make us an easy-to-work-with CDMO. ???????? ????????????????????????: Dive into our advanced offerings in small molecules, cell and gene therapies, and analytical services. ???????? ???????????? ??????????????: Learn about our high-capacity facilities delivering excellence across the globe ?????????????????? ????????????????: Stay up-to-date with industry insights and SK pharmteco news Check it out today and discover how we’re inspiring waves of change and impacting the landscape of pharmaceutical manufacturing: www.skpharmteco.com #CDMO #innovation #SKpharmteco #websitelaunch #globalsolutions

At SK pharmteco, we believe great companies must lead by example in environmental sustainability, and we are committed to reducing our environmental impact while supporting the development of life-changing therapies. As part of this commitment, we are proud to be pursuing My Green Lab Certification, the gold standard for sustainable laboratory practices. ? We've completed our baseline assessment and are on track to achieve our first certification level by summer 2025, with the ultimate goal of reaching the highest certification by 2030. This initiative directly supports our net zero carbon ambitions, reinforcing our 35% reduction in greenhouse gas emissions and our commitment to responsible operations. ? "This is more than a certification—it’s a path for our teams to leverage their expertise in creating a more sustainable workplace," says David Lowndes, SK pharmteco’s COO. ? Through our Responsible Manufacturing, Decarbonizing Operations, and Waste-Less Innovation strategies, we're embedding sustainability into everything we do. Join us on this journey toward a greener, more sustainable future! ?? ? Read the full press release here: https://lnkd.in/e7z-GKgH ? #Sustainability #ESG #NetZero #GreenLabs #SustainableManufacturing #CDMO

What’s shaping the small molecule CDMO landscape in 2025? From the rising demand for GLP-1s and peptides to shifting supply chains and evolving regulatory pressures, the industry is undergoing significant change. ? In a new Q&A, Steve Barr shares his insights on market trends, manufacturing capacity, and how SK pharmteco is investing to expand small molecule and peptide synthesis capabilities. He also explores the role of sustainability, emerging technologies, and the future of CDMO collaboration. ? Read the full article below: ? #CDMO #smallmolecules #APIs #sustainablemanufacturing

We are excited to kick off DCAT Week 2025 at the Member Company Announcement Forum on Monday, March 17! This highly anticipated event brings together industry leaders to share major updates with DCAT Week’s influential attendees and press. Join us as SK pharmteco’s Joyce Fitzharris, Head of Small Molecule Europe, shares key updates on our expansion in Small Molecule API, Peptide, and Plasmid Production. We’re honored to be part of this prestigious forum—thank you DCAT (Drug, Chemical & Associated Technologies Association) for the opportunity! Looking forward to connecting with industry peers at this exciting event. ?? March 17, 2025 | 9:00-11:30 AM | InterContinental Barclay, Grand Ballroom (2nd Floor) #DCATWeek2025 #CDMO #SmallMolecules #APIs

Celebrating Healthcare Science Week! ?? This week, we shine a spotlight on the incredible advancements in healthcare science and the dedicated professionals driving innovation in the industry. From groundbreaking research to transformative therapies, healthcare science continues to shape a healthier future for all. At SK pharmteco, we’re proud to contribute to this dynamic field by supporting the development and manufacturing of life-changing treatments. Here’s to the scientists, researchers, and innovators who are making a difference every day! #HealthcareScienceWeek #pharmaceuticalmanufacturing #biopharma #CDMO #APIs #CGT

A proud achievement for SK pharmteco! ?? We are honored to be a winner of the Outsourced Pharma 2025 CDMO Leadership Award in Cell & Gene Therapy Global. This recognition reflects our commitment to delivering world-class CDMO and analytical services that accelerate life-changing therapies from concept to patient. This award highlights excellence in the CDMO industry, and we are proud to be recognized alongside other industry leaders who are shaping the future of innovative medicine. A heartfelt thank you to our partners for your continued support and collaboration. We’re grateful to have you as part of our journey! Life Science Connect #CDMOLeadershipAwards #CDMO #advancedtherapies #cgt

Flexibility and responsiveness are imperative when developing therapies for rare diseases. With small patient populations, complex regulatory pathways, and the need for specialized manufacturing, speed and precision are critical. This is where CDMOs, like SK pharmteco, make all the difference by offering: ??Adaptable Manufacturing – Tailored solutions for small-batch, highly specialized therapies like cell and gene treatments. ??Accelerated Timelines – Expertise that streamlines processes and optimizes regulatory pathways. ??Resource Optimization – Access to cutting-edge infrastructure without heavy capital investment. ??Regulatory Expertise – Guidance that simplifies approvals and clinical trial design. ??Seamless Scalability – From clinical trials to commercial production, ensuring patient access. CDMOs provide the agility and expertise needed to transform innovation into life-changing treatments—faster and more efficiently. Learn more about how their flexibility and responsiveness are driving the future of rare disease drug development: https://lnkd.in/eTzrMGCR ?#raredisease #RareDiseaseDay #CDMO #advancedtherapies #smallmolecules #cgt #analyticalservices

We are proud to announce our partnership with Greater Paris University Hospitals - AP-HP and Institut Imagine to support the development of an innovative gene therapy for sickle cell disease. Through our LentiSure? platform, SK pharmteco Cell & Gene Europe will produce a 200L CGMP clinical batch of lentiviral vector (LVV) and provide regulatory support, marking a significant milestone on the path to clinical trials. ? This collaboration represents a major step forward in the fight against sickle cell disease, a devastating rare genetic disorder affecting millions worldwide. We are honored to work alongside leading researchers and institutions to translate groundbreaking science into potential life-changing treatments. ? Together, we are pushing the boundaries of what’s possible in cell and gene therapy. ? To read the full press release: https://lnkd.in/erbekAiW AFM-Téléthon INSERM #GeneTherapy #SickleCell #CellAndGeneTherapy #SKpharmteco #LentiSure

Attending Advanced Therapies Congress in London on March 18-19? Find us at us at Booth # 46 and catch SK pharmteco's Damien FERHADIAN's presentation on: "???????????????????? ?????????????????? ???????? ?????????? ???????????? ?????????????????????????? ?????????????????? ?????? ???????????????? ????????????????." Book a meeting to connect with one of our experts: https://lnkd.in/e5Vt85bT Don’t miss out on the latest in gene therapy innovations. See you there! ?? #CDMO #AdvancedTherapies #viralvector #plasmids

March is Colorectal Cancer Awareness Month??? Colorectal cancer is the second leading cause of cancer-related deaths worldwide, yet early detection can make all the difference. Screening and prevention efforts have the power to save lives, and as advancements in diagnostics and therapeutics continue, the fight against CRC grows stronger. At SK pharmteco, we are committed to supporting scientific innovation while ensuring regulatory compliance and patient safety. Our advanced analytical testing plays a critical role in the development of life-changing treatments, from small molecule APIs to complex therapies. Join us in spreading awareness—encourage screening, support research, and advocate for prevention. #ColorectalCancerMonth #CRCAwareness #CDMO #smallmolecules #APIs #analyticalservices